Potentiation of the antimicrobial effect of Lactobacillus reuteri DSM 17938 cell-free extracts by ascorbic acid.
DOI:
https://doi.org/10.26641/2307-0404.2020.1.200393Keywords:
combinatorial (precursor-directed) biosynthesis, Lactobacillus reuteri DSM 17938 derivatives, modified ascorbic acid, HPLC-analysisAbstract
The purpose of this study was to evaluate the effect of supplementing the culture medium with ascorbic acid on the antimicrobial properties of Lactobacillus reuteri cell-free extracts (CFEs). CFEs were prepared using commercial strain L. reuteri DSM 17938 by culturing lactobacilli in its own disintegrated cell suspension (DCS) supplemented with ascorbic acid in sub-inhibitory (5 mg/ml, CFE5) or minimal inhibitory concentration (20 mg/ml, CFE20) and without supplementation (CFE0). Staphylococcus aureus AТСС 25923, Escherichia coli AТСС 25922 reference strains and Pseudomonas aeruginosa extensively drug resistant (XDR) clinical isolate were used as indicator cultures. Screening of the inhibitory properties of the studied CFEs and elucidation of the nature of inhibitory products were done using modified Micro scale Optical Density Assay (MODA). The inhibition indices (InhI) were calculated for the studied CFEs and ascorbic acid of appropriate concentrations. CFEs were subjected to HPLC-analysis. CFE5 and CFE20 showed significantly higher antimicrobial activity toward to indicator cultures than CFE0. InhI calculated for extracts CFE5 and CFE20 mainly exceeded the sum of the corresponding indicators calculated for CFE0 and ascorbic acid (АА) of appropriate concentrations: InhICFE5 ≥ InhI CFE0 + InhI AA5; InhICFE20 > InhI CFE0 + InhI AA20. Acidic metabolic products have made the greatest contribution to the antimicrobial effect of the studied CFEs. HPLC-nalysis showed that the modified ascorbic acid was the substance found in CFE20 in the greatest quantity. The revealed effect of potentiation of antimicrobial activity of CFEs by ascorbic acid should be taken into account when developing new biotechnological products based on derivatives of L. reuteri DSM 17938.
References
Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, et al. Alternatives to antibiotics - a pipeline portfolio review. Lancet Infect Dis. 2016;16(2):239-51.
Greifová G, Májeková H, Greif G, Body P, Greifová M, Dubničková M. Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. Folia Microbiol. 2017;62(6):515-24. doi: http://dx.doi.org/10.1007/s12223-017-0524-9
Stefania DM, Miranda P, Diana M, Claudia Z, Rita P, Donatella P. Antibiofilm and antiadhesive activities of different synbiotics. J Probiotics Health. 2017;5(3):1000182.
Navarro JB, Mashburn-Warren L, Bakaletz LO, Bailey MT, Goodman SD. Enhanced probiotic potential of Lactobacillus reuteri when delivered as a biofilm on dextranomer microspheres that contain beneficial cargo. Front Microbiol. 2017;8:489. doi: http://dx.doi.org/10.3389/fmicb.2017.00489
Etchebehere MC, Piveta C, Levy CE. The influence of glycerol upon L. reuteri activity against enteropathogens. Medical Express. 2017;4(6). doi: http://dx.doi.org/10.5935/medicalexpress.2017.06.06
Glantz SA. Primer of biostatistics. 7th ed. New York: McGraw-Hill; 2012. p. 327
Knysh OV, Isayenko OY, Voyda YV, Kizimenko OO, Babych YM. Influence of cell-free extracts of Bifidobacterium bifidum and Lactobacillus reuteri on proliferation and biofilm formation by Escherichia coli and Pseudomonas aeruginosa. Regul Mech Biosyst. 2019;10(2):251-6. doi: http://dx.doi.org/10.15421/021938
Lash BW, Gourama H, Mysliwiec TH. Microscale assay for screening of inhibitory activity of Lactobacillus. BioTechniques. 2002;33(6):1224-8. doi: http://dx.doi.org/10.2144/02336bm08
Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. 2018;9:757. doi: http://dx.doi.org/10.3389/fmicb.2018.00757
Spinler JK, Auchtung J, Brown A, Boonma P, Oezguen N, Ross CL, et al. Next-generation probiotics targeting Clostridium difficile through precursor-directed antimicrobial biosynthesis. Infect Immun. 2017;85(10):e00303-17. doi: http://dx.doi.org/10.1128/iai.00303-17
Panda L. Antibacterial activity of ascorbic acid: pH effect, specific action or both? In abstracts of papers of the American chemical society (Vol. 255). 1155 16TH ST, NW, Washington, DC 20036. USA: Amer Chemical Soc; 2018. doi: http://dx.doi.org/10.13140/RG.2.2.22321.48482
Piqué N, Berlanga M, Miñana-Galbis D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int J Mol Sci. 2019;20(10):2534. doi: http://dx.doi.org/10.3390/ijms20102534
Ang EL, Sun H, Liu Z, Zhao H. Recent advances in combinatorial biosynthesis for drug discovery. Drug Des Devel Ther. 2015;823. doi: http://dx.doi.org/10.2147/dddt.s63023
Singh A, Vishwakarma V, Singhal B. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities-Metabiotics: Probiotics Effector Molecules. Advances in Bioscience and Biotechnology. 2018;9(4):147-89. doi: http://dx.doi.org/10.4236/abb.2018.94012
Martynov AV, Bomko TV, Farber BS, Nosalskaya TN, Kleyn I. Synthesis of dynamic riboflavin derivatives and the study of their ability to urease photoinactivation. Annals of Mechnikov Institute. 2019;3:44-49. doi: http://doi.org/10.5281/zenodo.3469432.
Verghese RJ, Mathew SK, David A. Antimicrobial activity of Vitamin C demonstrated on uropathogenic Escherichia coli and Klebsiella pneumoniae. J Curr Res Sci Med. 2017;3:88-93 doi: http://dx.doi.org/10.4103/jcrsm.jcrsm_35_17
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
